Phorm Corp Share Discussion Threads

[igbertsponk] 20/4/2016 15:38

says the man who stalked a man for ramping a share he didn't own.

Guess that makes you saddoe supreme.

[12bn] 20/4/2016 15:35

Andy Pipkin 19 Apr'16 - 18:22 - 51373 of 51382 0 0

So you've been unable to get a life then?

PingusP 19 Apr'16 - 20:56 - 51374 of 51382 0 0

So you've been unable to get a life then?

says the man who wasted his life ramping a share he says he didnt own.

lmao

[igbertsponk] 20/4/2016 15:02

Bandwidth stolen. How quaint. And about as relevant these days as having your slate chipped.

[rigmarole] 20/4/2016 14:07

If lots of people didn't think they were necessary, they wouldn't use them and advertisers wouldn't be moaning about how they're breaking the Internet. Maybe Igbert likes having his bandwidth stolen and his browsing interrupted and intercepted.

[igbertsponk] 20/4/2016 13:30

Blockers aren't necessary. I've never needed one.

[rigmarole] 20/4/2016 12:32

Not sure what Igbert's post has to do with Phorm, but that aside...

Does Igbert have any idea why ad blockers became necessary in the first place? And consider the source of the so-called research in the article.

[igbertsponk] 20/4/2016 12:27

Good job the huggers never make enough money or have any friends to go on holiday with. They'd not be able to check in!

[btcustomer] 20/4/2016 08:34

1. It's still live, which is a bit odd, given that phorm.com and phluidmedia.com have disappeared.
2. English language links and text relating to AIM etc (similar to text on Phorm sites) appeared then disappeared a few days later in November. (all recorded)
3, Further small changes were made yesterday.

If I was a crditor such as Bigger I'd be having Phorm's relationship with iMarker investigated very carefully. Did they own it? Has it been quietly disposed of before Phorm went bust. Did they EVER own it? Who owns iMarker now? Who has the rights to whatever software being operated right now by imarker.com, imrk.net imarker.ru and imrkcrv.net?

Then he might want to follow up licensing arrangements with, and ownership of Phorm China (and Phorm Korea and PTReklam and whatever they called their Brazilian operations) and carefully examine the inter-group finances to see what happened to all that cash and where it might be now. For a company that achieved so little, they burned an awful lot of cash. Are all of those outfits wholly owned group subsidiaries? Or are other parties involved? Do any of the institutional shareholders have involvlement in any relationships with such "other parties"? Who owns Viollette and Meditor?

And maybe someone knows where all that Huawei DPI hardware ended up?

[deko] 20/4/2016 06:01

imarker! tell us what has been changing.

[btcustomer] 19/4/2016 21:44

Interesting ongoing phallout from the Phorm phailure.



FiveT Capital and Spear Point Capital, two activist hedge funds that own nearly 10 percent of the company’s stock, had pushed for Lex Fenwick, a former top executive at Dow Jones and Bloomberg, to get a seat on the board along with FiveT head Johannes M. Roth.

In a filing Friday with Securities and Exchange Commission, TheStreet stated, “On April 15, 2016, the Company notified the Stockholders that, although it had carefully considered their nominees, the Board determined that Keith Hall and Larry Kramer remained the best choices to serve on the Company’s Board. The Company expects to continue to have an active engagement and dialogue with the Stockholders and other stockholders.”

Phorm does seem to be rather an embarrassment to many of their former employees/board members/directors. Reminds me of those Morecambe and Wise cameos - former actors looking destitute then saying, "I appeared in one of Ernie Wise's plays".

Anyone know anything about the ownership of iMarker? There have been interesting things happening on the imarker website recently.

[pingusp] 19/4/2016 20:56

So you've been unable to get a life then?

says the man who wasted his life ramping a share he says he didnt own.

lmao

[andy pipkin] 19/4/2016 18:22

So you've been unable to get a life then?

[btcustomer] 18/4/2016 23:05

Remember that iMarker was never named as the source of revenue - merely "Russia". The question of iMarker ownership remains worryingly murky. The claims about "doubled" Russian revenues in Q2 2015 were from unaudited interim results and related to very small amounts, quoted in Roubles to make them look more impressive.

I said at the time it looked odd. It looks even odder now.

iMarker and the associated domains are an asset. Who owns them?
If they have ceased trading why is the website still online?

Is imarker Russian? Odd that the name is always given in Latin rather than cyrillic script?

Who'se paying the rent for the office, the phone, and the web/mail hosting?
119270 Мос;квk2;, Луж;неm4;ка03; наб;ерk7;жн 72;я, дом; 2/4, кор;пуl9; 8

e-mail: [e-mail]

[phone]

[bluecar1] 18/4/2016 19:43

the revenues from imarker did get a mention in several set of results / updates (although not mentioned by name), which would normally indicate it was part of phorm, so will it die? or be sold off?

[btcustomer] 18/4/2016 15:15

Andy Pipkin - 15 Apr'16 - 15:48 - 51358 of 51368
12iq

I havnt held a share in this dog for over 7 years. Sorry to disappoint you.


If Andy Pipkin hasn't owned any phorm shares since around 2009, perhaps he could wriggle out of this post?


Andy Pipkin - 02 Dec 2014 - 15:12:37 - 46023 of 51369
Ah bless. A plethora of simpletons descend on the thread after the share falls 0.25p.

Some of us are still spending the proceeds of the surge from 2p to nearly 20p. Others are just looking on, turning greener by the day.

given that the rise from 2 to 20p happened in 2013?

Another blatant lie?

Or maybe he was using the royal "us"?

Either way - misleading information deliberately posted.

Andy Pipkin credibilty -35.60

Anyone know who owns iMarker and associated web assets?

[bluecar1] 18/4/2016 12:02

deko

just need it officially buried with stake through heart from companies house here and deleware

just remember phorm have made more come backs than the rolling stones and status quo combined

[deko] 17/4/2016 23:06

still dead.

[btcustomer] 17/4/2016 20:03

Clearly Andy Pipkin does - he's so DISinterested that he's taken his Phorm discussion to another thread!



ROFL!

Ramping without holding since 2009? (according to him).
ROFL!

Credibiliity still -35.60

Anyone know who actually owns iMarker? I'm sure Phorm creditors would be interested.

[btcustomer] 16/4/2016 21:37

Phorm are phinally phinished.

So much for all those misleading ramps!
The cash ran out.
The revenues never arrived.
The investors finally gave up.

Even the CEO is gone - Phorm's phone will be answered by a NY litigator specialising in bankruptcy hearings.

Bye. Parting is such sweet sorrow. Must go - I have a bottle of Kent sparkling wine to open!



Phorm Corporation Limited Update and Resignation of Nominated Adviser
14/04/2016 9:00am
UK Regulatory (RNS & others)

Phorm Corp (LSE:PHRM)
Historical Stock Chart

1 Month : From Mar 2016 to Apr 2016
Click Here for more Phorm Corp Charts.

TIDMPHRM

RNS Number : 2041V

Phorm Corporation Limited

14 April 2016

14 April 2016

Phorm Corporation Limited

("Phorm" or the "Company")

Financial and Operational Update

and Resignation of Nominated Adviser

Phorm (AIM: PHRM), an advertising-technology company and first party data platform provider, announces that, further to its announcement of 16 March 2016 and extensive discussions with certain of its shareholders and third parties, despite the Company's best efforts in securing financing, it has regrettably been unable to secure the additional equity and/or debt funding required for the group to continue its operational activities. Accordingly, the board of directors of Phorm (the "Board"), having taken appropriate legal advice, is in the process of ceasing the group's trading activities and taking the necessary steps to significantly reduce the group's headcount and overheads.

Having commenced an orderly cessation of the group's operations, the Board is mindful that in light of the Company's uncertain financial position, lack of trading activities and absence of any suitable funding, the Board or the Company's major shareholders and/or creditors may, subject to applicable law and restructuring advice, in due course, seek for the Company and/or group affiliated companies to commence appropriate insolvency proceedings, such as administration or liquidation. Regrettably, the Board does not anticipate that shareholders will receive any proceeds in relation to their ordinary shares from any such insolvency proceedings.

Accordingly, the Company's nominated adviser, has resigned with immediate effect, resulting in the automatic cancellation of the Company's ordinary shares of nil par value each from trading on the AIM market of the London Stock Exchange plc ("AIM") in 30 days, in accordance with Rule 1 of the AIM Rules for Companies, should the Company not appoint a replacement nominated adviser within that time ("Cancellation"). Pending such Cancellation, the Company's ordinary shares will remain suspended from trading on AIM.

The Board notes that the Company's website is currently unavailable due to overdue amounts owed to its supplier of hosting services, which the Company is not currently in a position to satisfy, such that the website is not expected to become available prior to Cancellation.

A further announcement(s) will be made by the Company in due course as appropriate.

-Ends-

For further information please contact:

Phorm Corporation Limited

Thomas Baylis [phone]

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCIIMPTMBABMJF

(END) Dow Jones Newswires

April 14, 2016 05:00 ET (09:00 GMT)

[btcustomer] 16/4/2016 21:37

Phorm are phinally phinished.

So much for all those misleading ramps!
The cash ran out.
The revenues never arrived.
The investors finally gave up.

Even the CEO is gone - Phorm's phone will be answered by a NY litigator specialising in bankruptcy hearings.

Bye. Parting is such sweet sorrow. Must go - I have a bottle of Kent sparkling wine to open!



Phorm Corporation Limited Update and Resignation of Nominated Adviser
14/04/2016 9:00am
UK Regulatory (RNS & others)

Phorm Corp (LSE:PHRM)
Historical Stock Chart

1 Month : From Mar 2016 to Apr 2016
Click Here for more Phorm Corp Charts.

TIDMPHRM

RNS Number : 2041V

Phorm Corporation Limited

14 April 2016

14 April 2016

Phorm Corporation Limited

("Phorm" or the "Company")

Financial and Operational Update

and Resignation of Nominated Adviser

Phorm (AIM: PHRM), an advertising-technology company and first party data platform provider, announces that, further to its announcement of 16 March 2016 and extensive discussions with certain of its shareholders and third parties, despite the Company's best efforts in securing financing, it has regrettably been unable to secure the additional equity and/or debt funding required for the group to continue its operational activities. Accordingly, the board of directors of Phorm (the "Board"), having taken appropriate legal advice, is in the process of ceasing the group's trading activities and taking the necessary steps to significantly reduce the group's headcount and overheads.

Having commenced an orderly cessation of the group's operations, the Board is mindful that in light of the Company's uncertain financial position, lack of trading activities and absence of any suitable funding, the Board or the Company's major shareholders and/or creditors may, subject to applicable law and restructuring advice, in due course, seek for the Company and/or group affiliated companies to commence appropriate insolvency proceedings, such as administration or liquidation. Regrettably, the Board does not anticipate that shareholders will receive any proceeds in relation to their ordinary shares from any such insolvency proceedings.

Accordingly, the Company's nominated adviser, has resigned with immediate effect, resulting in the automatic cancellation of the Company's ordinary shares of nil par value each from trading on the AIM market of the London Stock Exchange plc ("AIM") in 30 days, in accordance with Rule 1 of the AIM Rules for Companies, should the Company not appoint a replacement nominated adviser within that time ("Cancellation"). Pending such Cancellation, the Company's ordinary shares will remain suspended from trading on AIM.

The Board notes that the Company's website is currently unavailable due to overdue amounts owed to its supplier of hosting services, which the Company is not currently in a position to satisfy, such that the website is not expected to become available prior to Cancellation.

A further announcement(s) will be made by the Company in due course as appropriate.

-Ends-

For further information please contact:

Phorm Corporation Limited

Thomas Baylis [phone]

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCIIMPTMBABMJF

(END) Dow Jones Newswires

April 14, 2016 05:00 ET (09:00 GMT)

[btcustomer] 16/4/2016 21:37

Phorm are phinally phinished.

So much for all those misleading ramps!
The cash ran out.
The revenues never arrived.
The investors finally gave up.

Even the CEO is gone - Phorm's phone will be answered by a NY litigator specialising in bankruptcy hearings.

Bye. Parting is such sweet sorrow. Must go - I have a bottle of Kent sparkling wine to open!



Phorm Corporation Limited Update and Resignation of Nominated Adviser
14/04/2016 9:00am
UK Regulatory (RNS & others)

Phorm Corp (LSE:PHRM)
Historical Stock Chart

1 Month : From Mar 2016 to Apr 2016
Click Here for more Phorm Corp Charts.

TIDMPHRM

RNS Number : 2041V

Phorm Corporation Limited

14 April 2016

14 April 2016

Phorm Corporation Limited

("Phorm" or the "Company")

Financial and Operational Update

and Resignation of Nominated Adviser

Phorm (AIM: PHRM), an advertising-technology company and first party data platform provider, announces that, further to its announcement of 16 March 2016 and extensive discussions with certain of its shareholders and third parties, despite the Company's best efforts in securing financing, it has regrettably been unable to secure the additional equity and/or debt funding required for the group to continue its operational activities. Accordingly, the board of directors of Phorm (the "Board"), having taken appropriate legal advice, is in the process of ceasing the group's trading activities and taking the necessary steps to significantly reduce the group's headcount and overheads.

Having commenced an orderly cessation of the group's operations, the Board is mindful that in light of the Company's uncertain financial position, lack of trading activities and absence of any suitable funding, the Board or the Company's major shareholders and/or creditors may, subject to applicable law and restructuring advice, in due course, seek for the Company and/or group affiliated companies to commence appropriate insolvency proceedings, such as administration or liquidation. Regrettably, the Board does not anticipate that shareholders will receive any proceeds in relation to their ordinary shares from any such insolvency proceedings.

Accordingly, the Company's nominated adviser, has resigned with immediate effect, resulting in the automatic cancellation of the Company's ordinary shares of nil par value each from trading on the AIM market of the London Stock Exchange plc ("AIM") in 30 days, in accordance with Rule 1 of the AIM Rules for Companies, should the Company not appoint a replacement nominated adviser within that time ("Cancellation"). Pending such Cancellation, the Company's ordinary shares will remain suspended from trading on AIM.

The Board notes that the Company's website is currently unavailable due to overdue amounts owed to its supplier of hosting services, which the Company is not currently in a position to satisfy, such that the website is not expected to become available prior to Cancellation.

A further announcement(s) will be made by the Company in due course as appropriate.

-Ends-

For further information please contact:

Phorm Corporation Limited

Thomas Baylis [phone]

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCIIMPTMBABMJF

(END) Dow Jones Newswires

April 14, 2016 05:00 ET (09:00 GMT)

[btcustomer] 16/4/2016 21:36

Phorm are phinally phinished.

So much for all those misleading ramps!
The cash ran out.
The revenues never arrived.
The investors finally gave up.

Even the CEO is gone - Phorm's phone will be answered by a NY litigator specialising in bankruptcy hearings.

Bye. Parting is such sweet sorrow. Must go - I have a bottle of Kent sparkling wine to open!



Phorm Corporation Limited Update and Resignation of Nominated Adviser
14/04/2016 9:00am
UK Regulatory (RNS & others)

Phorm Corp (LSE:PHRM)
Historical Stock Chart

1 Month : From Mar 2016 to Apr 2016
Click Here for more Phorm Corp Charts.

TIDMPHRM

RNS Number : 2041V

Phorm Corporation Limited

14 April 2016

14 April 2016

Phorm Corporation Limited

("Phorm" or the "Company")

Financial and Operational Update

and Resignation of Nominated Adviser

Phorm (AIM: PHRM), an advertising-technology company and first party data platform provider, announces that, further to its announcement of 16 March 2016 and extensive discussions with certain of its shareholders and third parties, despite the Company's best efforts in securing financing, it has regrettably been unable to secure the additional equity and/or debt funding required for the group to continue its operational activities. Accordingly, the board of directors of Phorm (the "Board"), having taken appropriate legal advice, is in the process of ceasing the group's trading activities and taking the necessary steps to significantly reduce the group's headcount and overheads.

Having commenced an orderly cessation of the group's operations, the Board is mindful that in light of the Company's uncertain financial position, lack of trading activities and absence of any suitable funding, the Board or the Company's major shareholders and/or creditors may, subject to applicable law and restructuring advice, in due course, seek for the Company and/or group affiliated companies to commence appropriate insolvency proceedings, such as administration or liquidation. Regrettably, the Board does not anticipate that shareholders will receive any proceeds in relation to their ordinary shares from any such insolvency proceedings.

Accordingly, the Company's nominated adviser, has resigned with immediate effect, resulting in the automatic cancellation of the Company's ordinary shares of nil par value each from trading on the AIM market of the London Stock Exchange plc ("AIM") in 30 days, in accordance with Rule 1 of the AIM Rules for Companies, should the Company not appoint a replacement nominated adviser within that time ("Cancellation"). Pending such Cancellation, the Company's ordinary shares will remain suspended from trading on AIM.

The Board notes that the Company's website is currently unavailable due to overdue amounts owed to its supplier of hosting services, which the Company is not currently in a position to satisfy, such that the website is not expected to become available prior to Cancellation.

A further announcement(s) will be made by the Company in due course as appropriate.

-Ends-

For further information please contact:

Phorm Corporation Limited

Thomas Baylis [phone]

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCIIMPTMBABMJF

(END) Dow Jones Newswires

April 14, 2016 05:00 ET (09:00 GMT)